North America and Europe Celiac Disease Market to 2032
Overview
The North America and Europe Celiac Disease Market is expected to reach a 202.06 USD Million by 2032 and is projected to grow at a CAGR of 8.83% from 2025 to 2032.
Revenue, 2024 (USD Million)
100.20
Forecast, 2032 (USD Million)
202.06
CAGR, 2024 - 2032
8.83%
Report Coverage
North America
North America and Europe Celiac Disease Market 2018-2032 USD Million
North America and Europe Celiac Disease Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 100.20 USD Million
- Projected Market Size (2032): 202.06 USD Million
- CAGR (2025-2032): 8.83%
Key Findings of North America and Europe Celiac Disease Market
- The North America and Europe Celiac Disease Market was valued at 202.06 USD Million in 2024.
- The North America and Europe Celiac Disease Market is likely to grow at a CAGR of 8.83% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription in Prescription Segment accounted for the largest share of the market with a revenue of 92.64 USD Million
- The fastest growing segment Adults in Population Segment grew Fastest with a CAGR of 9.55% during the forecast period from 2024 to 2032.
North America and Europe Celiac Disease Market Scope
North America and Europe Celiac Disease Market Segmentation & Scope
Treatment
- Immunosuppressants
- Corticosteriods
- Others
Diseases
- Refractory Celiac Disease
- Non-Classical Celiac Disease
- Classical Celiac Disease
- Potential Celiac Disease
- Dermatitis Herpetiformis
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Home Care Settings
- Clinics
- Hospitals
Dosage Form
- Injections
- Capsules
- Tablet
- Others
Prescription
- Over The Counter
- Prescription
Drug
- Branded
- Generics
Route of Administration
- Oral
- Topical
- Intravenous
Population
- Geriatric
- Children
- Adults
North America and Europe Celiac Disease Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 100.20 USD Million |
| Market Value in 2032 | 202.06 USD Million |
| CAGR (2025-2032) | 8.83% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment,Diseases,Distribution Channel,End User,Dosage Form,Prescription,Drug,Route of Administration,Population |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 100.20 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 87.15 USD Million in 2024.
Segments and Scope
-
North America and Europe Celiac Disease Market to 2032, By Treatment
- Corticosteriods is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 69.15 USD Million in the year 2024.
- Corticosteriods is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.05 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By Diseases
- Refractory Celiac Disease is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 50.49 USD Million in the year 2024.
- Refractory Celiac Disease is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.37 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 66.53 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.24 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By End User
- Hospitals is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 66.68 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.23 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By Dosage Form
- Tablet is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 76.09 USD Million in the year 2024.
- Tablet is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.08 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By Prescription
- Prescription is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 92.64 USD Million in the year 2024.
- Prescription is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.01 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By Drug
- Generics is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 79.40 USD Million in the year 2024.
- Generics is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 8.93 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By Route of Administration
- Oral is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 75.08 USD Million in the year 2024.
- Oral is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.24 % in forecast period 2025-2032.
-
North America and Europe Celiac Disease Market to 2032, By Population
- Adults is the largest segment in North America and Europe Celiac Disease Market to 2032 with a revenue of 59.63 USD Million in the year 2024.
- Adults is the Fastest growing segment in North America and Europe Celiac Disease Market to 2032 with a Growth rate of 9.55 % in forecast period 2025-2032.
North America and Europe Celiac Disease Market Company Share Analysis
North America and Europe Celiac Disease Market Geographical Sales Distribution, 2018-2032 USD Million
North America and Europe Celiac Disease Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America and Europe Celiac Disease Market is segmented based on Segmentation Treatment,Diseases,Distribution Channel,End User,Dosage Form,Prescription,Drug,Route of Administration,Population.
North America and Europe Celiac Disease Market was valued at USD 100.20(Revenue in USD Million) in 2022.
North America and Europe Celiac Disease Market is projected to grow at a CAGR of 8.83% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the North America and Europe Celiac Disease Market, holding a largest market share of 92.64 USD Million in 2024
North America and Europe Celiac Disease Market Scope
North America and Europe Celiac Disease Market Segmentation & Scope
Treatment
- Immunosuppressants
- Corticosteriods
- Others
Diseases
- Refractory Celiac Disease
- Non-Classical Celiac Disease
- Classical Celiac Disease
- Potential Celiac Disease
- Dermatitis Herpetiformis
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Home Care Settings
- Clinics
- Hospitals
Dosage Form
- Injections
- Capsules
- Tablet
- Others
Prescription
- Over The Counter
- Prescription
Drug
- Branded
- Generics
Route of Administration
- Oral
- Topical
- Intravenous
Population
- Geriatric
- Children
- Adults
Frequently Asked Questions
The North America and Europe Celiac Disease Market is segmented based on Segmentation Treatment,Diseases,Distribution Channel,End User,Dosage Form,Prescription,Drug,Route of Administration,Population.
North America and Europe Celiac Disease Market was valued at USD 100.20(Revenue in USD Million) in 2022.
North America and Europe Celiac Disease Market is projected to grow at a CAGR of 8.83% during the forecast period of 2024 to 2032.
The estimated market value of the North America and Europe Celiac Disease Market for final year is USD 202.06 (USD Million).
North America and Europe Celiac Disease Market Company Profiling
Frequently Asked Questions
The North America and Europe Celiac Disease Market is segmented based on Segmentation Treatment,Diseases,Distribution Channel,End User,Dosage Form,Prescription,Drug,Route of Administration,Population.
North America and Europe Celiac Disease Market was valued at USD 100.20(Revenue in USD Million) in 2022.
North America and Europe Celiac Disease Market is projected to grow at a CAGR of 8.83% during the forecast period of 2024 to 2032.
The estimated market value of the North America and Europe Celiac Disease Market for final year is USD 202.06 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.